Regulatory Due Diligence Could Offset Foreign Manufacturing Cost-Savings
This article was originally published in The Tan Sheet
Executive Summary
Companies that seek to save costs by manufacturing products outside the U.S. might in some cases pay a price to come into regulatory compliance for the U.S. market, FDA executives caution
You may also be interested in...
HHS Food Safety Enforcement Report May Heat Up Congressional Interest
A Department of Health and Human Services report showing declining food safety inspections and actions could give a boost to "Food Modernization" legislation pending in Congress
FDA Foreign Inspections To Double In 2010, Led By Human Drugs And Food
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC